Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. COSMOS Pharmaceutical Corporation
  6. Summary
    3349   JP3298400007

COSMOS PHARMACEUTICAL CORPORATION

(3349)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Japan Exchange
07/15/2021 07/16/2021 07/19/2021 07/20/2021 07/21/2021 Date
17750 17850 17890 18140 18100 Last
184300 150100 108100 174100 146600 Volume
+0.57% +0.56% +0.22% +1.40% -0.22% Change
Estimated financial data (e)
Sales 2021 728 B 6 595 M 6 595 M
Net income 2021 25 440 M 231 M 231 M
Net cash position 2021 51 429 M 466 M 466 M
P/E ratio 2021 28,2x
Yield 2021 0,32%
Sales 2022 765 B 6 934 M 6 934 M
Net income 2022 25 242 M 229 M 229 M
Net cash position 2022 67 845 M 615 M 615 M
P/E ratio 2022 28,3x
Yield 2022 0,36%
Capitalization 717 B 6 484 M 6 494 M
EV / Sales 2021 0,91x
EV / Sales 2022 0,85x
Nbr of Employees -
Free-Float 48,8%
More Financials
Company
COSMOS Pharmaceutical Corporation is a company primarily engaged in the operation of drug stores. The Company offers medical goods, including general self-medication products, tonic drinks, oral care products, nursing care products, vitamin supplements, health food products, diet food and dispensing. Cosmetic products include cosmetic products for women and men, hair care products and bath agents. Miscellaneous... 
Sector
Drug Retailers
Calendar
10/08Earnings Release
More about the company
Ratings of COSMOS Pharmaceutical Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about COSMOS PHARMACEUTICAL CORPORATION
07/13Topix closes at near one-month high as investors await earnings
RE
05/28COSMOS PHARMACEUTICAL CORPORATION : Ex-dividend day for final dividend
FA
2020COSMOS PHARMACEUTICAL CORPORATION : Ex-dividend day for interim dividend
FA
2020COSMOS PHARMACEUTICAL CORPORATION : SPLIT: 2 of 1
FA
2020COSMOS PHARMACEUTICAL CORPORATION : Ex-dividend day for final dividend
FA
2019COSMOS PHARMACEUTICAL CORP : Ex-dividend day for interim dividend
FA
2019COSMOS PHARMACEUTICAL CORP : Ex-dividend day for final dividend
FA
2018COSMOS PHARMACEUTICAL CORP : Ex-dividend day for interim dividend
FA
2018COSMOS PHARMACEUTICAL CORP : Ex-dividend day for final dividend
FA
2018Hidefuji Co., Ltd. acquired 5.25% stake in COSMOS Pharmaceutical Corporation ..
CI
2017COSMOS PHARMACEUTICAL CORP : Ex-dividend day for interim dividend
FA
2017COSMOS PHARMACEUTICAL CORP : Ex-dividend day for final dividend
FA
2016COSMOS PHARMACEUTICAL CORP : Ex-dividend day for interim dividend
FA
2016COSMOS PHARMACEUTICAL CORPORATION(TS : 3349) added to S&P Japan 500
CI
2016COSMOS PHARMACEUTICAL CORP : Ex-dividend day for final dividend
FA
More news
News in other languages on COSMOS PHARMACEUTICAL CORPORATION
07/13TOKYO STOCK EXCHANGE : Borsa Tokyo, Topix a massimi di quasi un mese, mercato at..
2019AVIS D'ANALYSTES DU JOUR : Capgemini, Total, Peugeot, Michelin, Maisons du Monde..
2019STOCK MARKET PARIS : Trump et Powell dans le même bas-taux ?
2019AVIS D'ANALYSTES DU JOUR : Airbus, Groupe ADP, Tarkett, Solutions 30, Boskalis, ..
2018AVIS D'ANALYSTES DU JOUR : Airbus, Altice, Kering, Nestlé, Ingenico...
More news
Chart COSMOS PHARMACEUTICAL CORPORATION
Duration : Period :
COSMOS Pharmaceutical Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COSMOS PHARMACEUTICAL CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 18 100,00 JPY
Average target price 17 600,00 JPY
Spread / Average Target -2,76%
EPS Revisions
Managers and Directors
Hideaki Yokoyama President & Representative Director
Masateru Uno Chairman
Masahiro Iwashita Director & Manager-Information Systems
Tetsuo Kino Independent Outside Director
Masao Ueda Independent Outside Director
Sector and Competitors